China Digest: Medbanks nabs $59m Series D; Shenzhen Lihexing snags $19m

Medisix
T-lymphocytes attack a migrating cancer cell. Visual from Medisix's website.

China’s oncology database firm Medbanks Network Technology has raised $59 million in a Series D round while Shenzhen Lihexing has secured a funding of nearly $19 million.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Should your colleagues be reading this article too? Contact us for corporate subscriptions at subs@dealstreetasia.com.